Research Article
Anti-GAPDH Autoantibody Is Associated with Increased Disease Activity and Intracranial Pressure in Systemic Lupus Erythematosus
Table 1
Characteristics of 130 SLE patients and 55 healthy controls.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
F: female; M: male; WBC: white blood cell; HB: hemoglobin; PLT: platelet count; IgG: immunoglobulin G; IgA: immunoglobulin A; IgM: immunoglobulin M; C3: complement component 3; C4: complement component 4; ESR: erythrocyte sedimentation rate; RF: rheumatoid factor; CRP: C-reaction protein; CK: creatine kinase; Cr: creatinine; anti-dsDNA: anti-double-stranded DNA antibodies; AnuA: anti-nucleosome antibodies; anti-SSA: anti-SSA antibody; anti-SSB: anti-SSB antibody; anti-RNP Abs: anti ribonucleoprotein (RNP) antibodies; ANA: anti-nuclear antibodies; SLEDAI-2K: systemic lupus erythematosus disease activity index 2000. |